Edgewise Therapeutics Inc
$ 38.43
-6.54%
31 Jul - close price
- Market Cap 4,134,799,000 USD
- Current Price $ 38.43
- High / Low $ 41.11 / 38.21
- Stock P/E N/A
- Book Value 4.59
- EPS -1.66
- Next Earning Report 2026-08-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.26 %
- ROE -0.38 %
- 52 Week High 48.40
- 52 Week Low 12.30
About
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The company is headquartered in Boulder, Colorado.
Analyst Target Price
$49.92
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-02-26 | 2025-11-06 | 2025-08-07 | 2025-05-08 | 2025-03-03 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-02-22 | 2023-11-09 | 2023-08-10 |
| Reported EPS | -0.46 | -0.47 | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 | -0.34 | -0.33 | -0.47 | -0.41 | -0.34 |
| Estimated EPS | -0.48 | -0.43 | -0.4 | -0.42 | -0.42 | -0.4222 | -0.37 | -0.34 | -0.41 | -0.43 | -0.4 | -0.4 |
| Surprise | 0.02 | -0.04 | 0.01 | 0.08 | -0.01 | 0.0022 | 0.01 | 0 | 0.08 | -0.04 | -0.01 | 0.06 |
| Surprise Percentage | 4.1667% | -9.3023% | 2.5% | 19.0476% | -2.381% | 0.5211% | 2.7027% | 0% | 19.5122% | -9.3023% | -2.5% | 15% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-06 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.48 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: EWTX
2026-07-29 23:53:53
The article provides a detailed analysis of Edgewise Therapeutics Inc. (NASDAQ: EWTX) using AI models, highlighting a mixed sentiment with near-term positive and mid-term weak biases
2026-07-27 20:40:09
This article provides a valuation analysis for Edgewise Therapeutics Inc (EWTX), focusing on its stock price, market capitalization, and key financial ratios like P/E, P/B, and P/CF. It notes that relevant data for these ratios have not yet been disclosed by the company. The stock closed at $41.590, up 1.84%, with a market cap of $4.42 billion.
2026-07-27 15:39:35
This article details the shareholder structure of Edgewise Therapeutics Inc (EWTX), listing major shareholders and their proportions, as well as a breakdown of shareholder types. It also provides institutional shareholding data over various quarters and lists related ETFs holding EWTX shares.
2026-07-27 12:39:35
This article provides a detailed balance sheet for Edgewise Therapeutics Inc (EWTX), presenting quarterly financial data for assets, liabilities, and shareholders' equity. It covers various line items including cash, investments, fixed assets, accrued expenses, and retained earnings, allowing for an in-depth analysis of the company's financial health over multiple quarters. The data is presented with year-over-year percentage changes for each financial metric.
2026-07-27 11:39:35
This article provides a technical analysis of Edgewise Therapeutics Inc (EWTX), detailing its performance based on various indicators and moving averages. It offers insights into the stock's current technical ratings, including buy, sell, and neutral signals from MACD, RSI, KDJ, and other common technical indicators. The analysis also covers moving averages (MA5 to MA200), all of which currently show buy signals for EWTX.
2026-07-27 04:39:35
This page on TradingView.com provides financial information for Edgewise Therapeutics, Inc. (EWTX) on the Nasdaq Stock Market. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segments. The article indicates that the market is closed, with no trades currently occurring for EWTX.
